Results 171 to 180 of about 425,345 (255)
Abstract Health inequalities persist along lines of income and wealth, shaped by unequal access to healthcare, differences in health behaviors, and pre‐existing chronic conditions. The COVID‐19 pandemic further put families in Korea under health strain and worsened their health outcomes.
Jaehyun Nam +3 more
wiley +1 more source
Child Mortality and Nutritional Risks in Rural Chad: A Community-Based Cross-Sectional Study in Béré. [PDF]
Boutrin MC +3 more
europepmc +1 more source
Racism and racial disparities in firearm violence: A scoping review
Abstract Firearm violence (i.e., interpersonal, police firearm violence) disproportionately affects racially minoritized communities. Researchers recently shifted their focus from race to racism to better understand the factors that contribute to racial disparities in firearm violence.
Daniel B. Lee +8 more
wiley +1 more source
When conflict meets political exclusion: Ethnicity, governance, and child mortality. [PDF]
Chang S, Ives B, Oh J.
europepmc +1 more source
ABSTRACT Management of cerebral vasculopathy in sickle cell anemia (SCA) includes standard‐care, that is, chronic transfusion (CT) or hydroxyurea, and hematopoietic cell transplantation (HCT). DREPAGREFFE‐1 (December 2010/June 2013), a French multicenter trial, was the first prospective trial comparing standard‐care to match sibling donor (MSD)‐HCT in ...
Francoise Bernaudin +40 more
wiley +1 more source
Innovative hematological strategies to combat maternal and child mortality in Africa: focus on anemia and sickle cell disease. [PDF]
Obeagu EI.
europepmc +1 more source
ABSTRACT Diamond–Blackfan Anemia Syndrome (DBAS) is a rare congenital anemia often requiring chronic red blood cell transfusions from infancy. Without appropriate chelation, iron overload develops early and may be severe; however, no data are available on chelation in patients under 3 years of age.
Francesca Torchio +19 more
wiley +1 more source
The maternal and child mortality in the Middle East and North Africa between 2000 and 2020: the role of health financing. [PDF]
Gao T, Farag M, Li G, Zeng W.
europepmc +1 more source
ABSTRACT Exagamglogene autotemcel (exa‐cel) is a one‐time, ex vivo, CRISPR‐Cas9 gene edited cell therapy approved for patients with transfusion dependent β‐thalassemia (TDT) aged 12–35 years. In a Phase 3 study (CLIMB THAL‐111), exa‐cel treatment resulted in reactivation of fetal hemoglobin and increases in total hemoglobin, leading to transfusion ...
Sujit Sheth +25 more
wiley +1 more source

